AE Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,635	Closed	-$521K	–	2127
2023 Q3	$521K	Buy	+4,635	New	+$521K	﹤0.01%	1349
2023 Q1	–	Sell	-5,723	Closed	-$684K	–	1956
2022 Q4	$684K	Sell	5,723 -42	-0.7%	-$5.02K	﹤0.01%	1146
2022 Q3	$612K	Buy	+5,765	New	+$612K	﹤0.01%	1140